NCT06661369 Study Comparing the Effects of SPM Techniques, Individually vs. Grouped in Children With ASD
| NCT ID | NCT06661369 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2024-09-26 |
| Primary Completion | 2025-01-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2024-09-26 with a primary completion date of 2025-01-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Autism is the most prevalent disorder as it affects attention, awareness, cognitive development, social development, and emotional aspects too. It is one of the comprehensive developmental disorders in the early stage, which is characterized by weak social learning and communication, limited activities, interests, learning, insufficient imaginative and stereotypical thinking or non-functional thinking of movements and verbalities. A lack of sensory perception leads to a leading autistic child\'s sensitivity to sensory stimuli or weak sensitivity and the child is not aware of the surrounding environment.
Eligibility Criteria
Inclusion Criteria: * Children who diagnosed with Autism Spectrum Disorder (mild \& moderate) according to Diagnostic and Statistical Manual of Mental Disorders, (DSM-5) * Have an IQ 70 according to Stanford-Binet Intelligence Scales * Children whose age between 4 to 12 * All participants had to be able to sit and walk without support Exclusion Criteria: * Children who will associate with attention deficit hyperactivity disorder signs * Upper limb musculoskeletal injuries * Visual or auditory impairments * Children who had received sensory integration therapy for \> 3 months within the past 6 months * Children with speech delay, hearing impairment, or intellectual disability
Contact & Investigator
Sara Sattar, MS*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06661369 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 12 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06661369 currently recruiting?
Yes, NCT06661369 is actively recruiting participants. Contact the research team at Imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06661369 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06661369 clinical trial?
NCT06661369 is sponsored by Riphah International University. The principal investigator is Sara Sattar, MS* at Riphah International University. The trial plans to enroll 36 participants.